...
首页> 外文期刊>Clinical journal of the American Society of Nephrology: CJASN >Longitudinal study of small solute transport and peritoneal protein clearance in peritoneal dialysis patients
【24h】

Longitudinal study of small solute transport and peritoneal protein clearance in peritoneal dialysis patients

机译:腹膜透析患者小溶质转运和腹膜蛋白清除率的纵向研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objectives: Peritoneal protein clearance (Pcl) is determined by both effective (small pores) membrane area and relative capillary leakiness (large pores). It is not known how these two components change with duration of peritoneal dialysis (PD) in the context of progressive membrane injury and differential attrition of patients with higher Pcl, which has been associated with increased mortality risk in several studies. Design, setting, participants, & measurements: Patients treated continuously from 2000 to 2011 for a minimum of 4 years were selected from the longitudinal prospective Stoke PD Study. Pcl, membrane area (peritoneal solute transport rate [PSTR]), dialysis prescription, and residual renal function were measured every 6 months, along with comorbidity and peritonitis events. Multilevel multivariate analysis was used to determine associations with Pcl over time, taking into account within-subject correlations. Results: From 280 incident patients, 335 datasets were analyzed from 49 patients receiving treatment for 4 years. Pcl correlated with PSTR at baseline (R=0.61; P<0.01), but over time there was progressive uncoupling of this relationship (year 4, R=0.28; P=0.05) with increasing PSTR (0.66-0.74; P<0.01) and stable Pcl (78.4-81.9 ml/d; P=0.7). Multivariate analysis found that age, PSTR, daily ultrafiltration, and sodium removal were significant predictors of Pcl when adjusted for sex, comorbidity, glucose exposure, and residual renal function. Peritonitis was associated with increased PSTR but a similar pattern of uncoupling. Conclusion: There is a progressive dissociation of the small- and large-pore pathways with time on PD, which would be in keeping with a switch from local inflammation early on to progressive fibrosis, combined with increased vascular surface area. Measuring longitudinal changes in Pcl may complement membrane function tests used to monitor progressive injury.
机译:背景与目的:腹膜蛋白清除率(Pcl)由有效(小孔)膜面积和相对毛细血管渗漏(大孔)共同决定。目前尚不清楚这两种成分在进行性膜损伤和Pcl较高的患者减员减员的情况下如何随着腹膜透析(PD)持续时间的变化而变化,这在一些研究中与死亡风险增加有关。设计,设置,参与者和测量:从纵向前瞻性Stoke PD研究中选择2000年至2011年连续治疗至少4年的患者。每6个月测量一次Pcl,膜面积(腹膜溶质转运率[PSTR]),透析处方和残余肾功能,以及合并症和腹膜炎事件。考虑到受试者之间的相关性,使用多级多变量分析确定随时间推移与Pcl的相关性。结果:从280名事件患者中,分析了49位接受4年治疗的患者的335个数据集。 Pcl与基线时的PSTR相关(R = 0.61; P <0.01),但随着时间的推移,这种关系逐步解除(第4年,R = 0.28; P = 0.05),而PSTR升高(0.66-0.74; P <0.01)和稳定的Pcl(78.4-81.9 ml / d; P = 0.7)。多变量分析发现,对性别,合并症,葡萄糖暴露和残余肾功能进行调整后,年龄,PSTR,每日超滤和钠去除是Pcl的重要预测指标。腹膜炎与PSTR升高有关,但解偶联类似。结论:PD上随着时间的推移,小孔和大孔途径逐渐分离,这与从早期局部炎症转变为进行性纤维化以及血管表面积增加保持一致。测量Pcl的纵向变化可补充用于监测进行性损伤的膜功能测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号